Meyer Benedicte, Nguyen Chinh Bkrong Thuy, Moen Aurora, Fagermoen Even, Sulheim Dag, Nilsen Hilde, Wyller Vegard Bruun, Gjerstad Johannes
Dept. of Paediatrics, Akershus University Hospital, Oslo, Norway.
Dept. of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, Norway; National Institute of Occupational Health, Oslo, Norway; Department of Biosciences, University of Oslo, Oslo, Norway.
PLoS One. 2015 Oct 16;10(10):e0140883. doi: 10.1371/journal.pone.0140883. eCollection 2015.
Earlier studies have shown that genetic variability in the SLC6A4 gene encoding the serotonin transporter (5-HTT) may be important for the re-uptake of serotonin (5-HT) in the central nervous system. In the present study we investigated how the 5-HTT genotype i.e. the short (S) versus long (L) 5-HTTLPR allele and the SNP rs25531 A > G affect the physical and psychosocial functioning in patients with chronic fatigue syndrome (CFS). All 120 patients were recruited from The Department of Paediatrics at Oslo University Hospital, Norway, a national referral center for young CFS patients (12-18 years). Main outcomes were number of steps per day obtained by an accelerometer and disability scored by the Functional Disability Inventory (FDI). Patients with the 5-HTT SS or SLG genotype had a significantly lower number of steps per day than patients with the 5-HTT LALG, SLA or LALA genotype. Patients with the 5-HTT SS or SLG genotype also had a significantly higher FDI score than patients with the 5-HTT LALG, SLA or LALA genotype. Thus, CFS patients with the 5-HTT SS or SLG genotype had worse 30 weeks outcome than CFS patients with the 5-HTT LALG, SLA or LALA genotype. The present study suggests that the 5-HTT genotype may be a factor that contributes to maintenance of CFS.
早期研究表明,编码血清素转运体(5-羟色胺转运体,5-HTT)的SLC6A4基因的遗传变异性可能对中枢神经系统中血清素(5-HT)的再摄取很重要。在本研究中,我们调查了5-HTT基因型,即短(S)与长(L)5-HTTLPR等位基因以及单核苷酸多态性rs25531 A>G如何影响慢性疲劳综合征(CFS)患者的身体和心理社会功能。所有120名患者均从挪威奥斯陆大学医院儿科招募,该科室是国家青少年CFS患者(12 - 18岁)转诊中心。主要结果是通过加速度计获得的每日步数以及功能残疾量表(FDI)评分的残疾程度。5-HTT SS或SLG基因型的患者每天的步数明显低于5-HTT LALG、SLA或LALA基因型的患者。5-HTT SS或SLG基因型的患者FDI评分也明显高于5-HTT LALG、SLA或LALA基因型的患者。因此,5-HTT SS或SLG基因型的CFS患者30周后的结果比5-HTT LALG、SLA或LALA基因型的CFS患者更差。本研究表明,5-HTT基因型可能是导致CFS持续存在的一个因素。